Inhibition of angiogenesis by non-toxic doses of temozolomide

Article Properties
Cite
Kurzen, Hjalmar, et al. “Inhibition of Angiogenesis by Non-Toxic Doses of Temozolomide”. Anti-Cancer Drugs, vol. 14, no. 7, 2003, pp. 515-22, https://doi.org/10.1097/00001813-200308000-00003.
Kurzen, H., Schmitt, S., Näher, H., & Möhler, T. (2003). Inhibition of angiogenesis by non-toxic doses of temozolomide. Anti-Cancer Drugs, 14(7), 515-522. https://doi.org/10.1097/00001813-200308000-00003
Kurzen H, Schmitt S, Näher H, Möhler T. Inhibition of angiogenesis by non-toxic doses of temozolomide. Anti-Cancer Drugs. 2003;14(7):515-22.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
10.1074/jbc.M107442200 Journal of Biological Chemistry
  • Science: Chemistry: Organic chemistry: Biochemistry
 2002
Tiny dancers

 The Journal of Cell Biology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Cytology
  • Science: Biology (General): Genetics
 36 2002
Inhibition of angiogenesis in vitro by αv integrin–directed antisense oligonucleotides Cancer Gene Therapy
  • Technology: Chemical technology: Biotechnology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Science: Biology (General): Genetics
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 16 2002
Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-δ and by mobilization of intracellular Ca2+

 Biochemical Journal
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 53 2001
In Vitro Models of Vasculogenesis and Angiogenesis Laboratory Investigation
  • Medicine: Medicine (General)
  • Medicine: Pathology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 244 2001
Refrences Analysis
Category Category Repetition
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens20
Medicine: Medicine (General)17
Science: Biology (General): Cytology8
Science: Biology (General)6
Science: Biology (General): Genetics6
Science: Chemistry: Organic chemistry: Biochemistry5
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs2
Medicine: Public aspects of medicine: Toxicology. Poisons2
Science: Science (General)1
Medicine: Medicine (General): Medical technology1
Medicine: Internal medicine1
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy1
Medicine: Surgery1
Science: Physics1
Medicine: Therapeutics. Pharmacology1
Science: Physiology1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system1
Technology: Chemical technology: Biotechnology1
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 20 is the most frequently represented among the references in this article. It primarily includes studies from Cancer Research The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial ESMO Open 2024
Nasal administration of a temozolomide-loaded thermoresponsive nanoemulsion reduces tumor growth in a preclinical glioblastoma model Journal of Controlled Release
  • Science: Chemistry: General. Including alchemy
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 9 2023
Metronomic Temozolomide (mTMZ) and Bevacizumab—The Safe and Effective Frontier for Treating Metastatic Neuroendocrine Tumors (NETs): A Single-Center Experience

 Cancers
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 2023
The Impact of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine

 Cells
  • Science: Biology (General): Cytology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General): Cytology
 1 2023
Combination therapy with interferon-gamma as a potential therapeutic medicine in rat's glioblastoma: A multi-mechanism evaluation Life Sciences
  • Medicine: Medicine (General)
  • Medicine: Therapeutics. Pharmacology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 7 2022
Citations Analysis
Category Category Repetition
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens33
Medicine: Medicine (General)30
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry13
Medicine: Therapeutics. Pharmacology13
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system12
Medicine: Public aspects of medicine: Toxicology. Poisons7
Science: Biology (General)5
Medicine: Medicine (General): Medical technology4
Medicine3
Science: Chemistry: Organic chemistry: Biochemistry3
Science: Science (General)2
Science: Biology (General): Cytology2
Science: Chemistry: General. Including alchemy2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system2
Medicine: Internal medicine1
Science1
Science: Biology (General): Genetics1
Science: Physics: Optics. Light1
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine1
Science: Physics: Acoustics. Sound1
Philosophy. Psychology. Religion: Psychology1
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Technology: Chemical technology: Biotechnology1
Medicine: Ophthalmology1
Technology: Home economics: Nutrition. Foods and food supply1
Science: Chemistry1
Medicine: Pharmacy and materia medica1
Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases1
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 33 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled A highly efficient electroporation method for the transfection of endothelial cells and was published in 2004. The most recent citation comes from a 2024 study titled A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial. This article reached its peak citation in 2012, with 6 citations. It has been cited in 49 different journals, 20% of which are open access. Among related journals, the Journal of Neuro-Oncology cited this research the most, with 7 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year